Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

0 structures for Q5UQR4

Entry ID Method Resolution Chain Position Source

No variants for Q5UQR4

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q5UQR4

No associated diseases with Q5UQR4

No regional properties for Q5UQR4

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q5UQR4

Functions

Description
EC Number
Subcellular Localization
  • Virion
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
virion component Any constituent part of a virion, a complete fully infectious extracellular virus particle.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MVDVYNELGL NYDPNFEEQR NLIDVYLRIY FPKIRPEEFI SILDFLNESA SDAKKGIEKN
70 80 90 100 110 120
KIRTVYDTIK NNLILENEPM RDIEITKKKY EKEYVKLFKE NYVTQSFIRA YLLDRGKKID
130 140 150 160 170 180
LFRIFDNFIL NENYPFIQYQ PPDGTPRSRY NEKYLLENER KEIIMKWFEN TPWGISFKVR
190 200 210 220 230 240
VSDKSDYKYM AINLSDNGRI DYKIQWKEED MQTVDDIDKT YSFVKDLIRK INRENERFGI
250 260 270 280 290 300
KLKIPSDDQF KFAFINTIQK FELPDNFAIN HNDLSEFSRY FFPYVALVIE PRKRQSKTKT
310 320 330 340 350 360
TERDERSKFG TYLRYKRVSK YDNKTKIEHR IVFFMRNYEY NDQSLSNEIS KEFNITEEQA
370 380 390 400 410 420
LEEINAVRER YPNIKKSRKV LKKLENIPKY KPPGIGVDIQ GKTRNNYKMR IAGARDRAQL
430 440 450 460 470 480
NRIITFMNIL IYLYAETYLY KRPDRQRMKD LLQKLTKIAR RRNKVDEIVN HETPIKSVKQ
490 500 510 520 530 540
MTNIDRKRLT SKTEDDQNQW TRDCQNSGED KKRRPQQFLN VEELQKLGYV WNPKLGDINF
550 560 570 580 590 600
GHYERKIMVD SNGRTDSNKK KSEVVLRAVM LPLDDSGNNY VYYTCGPEEN GKHMYIGFLK
610 620 630 640 650 660
SKNPYGEAKP CCFIKDQLYS KNNDKRNLFL KSIGLIQNDE SEVNKIVGDQ LYILQSSNKI
670 680 690 700 710 720
QEGRFAFLPK YLDIFLNAML NNERVIKNHY LVSTTTGYYF KYGTKQDEYR YLNAVGSVLD
730 740 750 760 770 780
LSIEDLRNKL SSSLTKDKNQ LLFTSLNNGD IRAQFGSMES YLTYINTNKY LEYPLLNDLI
790 800 810 820 830 840
CSPGVINKYG LNIIIFQRKI RIIRKSFERE KIREHYYIVC QNHENIEDLI DPDRETILIV
850 860 870 880 890 900
KEGKNYYPII LVKKEDENTK EVSITKTFQY NSNPENIVSH IFKYYEVNCQ QEFKLLIKEK
910 920 930 940 950 960
SNSNLNAKET NKILISLGIK EYVPKYQMID ARFKCRYLIT NAGYIIPVIP SGIVKNVNII
970 980 990 1000 1010 1020
STVNNYLKDY TTTQKYLTDL SKLTKNKLKI KPIGVFYKDK RQKSYVISAI MTEGYDAVPI
1030 1040 1050 1060 1070 1080
IERSMTSEYI KKEKLLTQGR PNDEDIDRDI SRGKSSIVVD KRVYEVSKNK YETETYQLFR
1090 1100 1110 1120 1130 1140
YHLSYFLNNT TEGGKFKKEI ENIINSEDIN KRERKLELKN VLYRMTNADL SKTFNQLISR
1150 1160 1170 1180 1190 1200
LNKQFGGQDN VSDQSENQSE NQSLESETSP IVRELNPLTQ ANSPISIIQE PDTIQIIPED
1210 1220 1230 1240 1250 1260
FVPGRRNNLR ESFVNTDVDE FDYSEQINPL DEPFDYATNK EPMAESVPFP KNEKTWLSIM
1270 1280 1290 1300 1310 1320
PDSKIIDYPS YILKNNREYC YINKNKDACN INKHCAWNNS KNLCLFNVKR IQLIDFINQV
1330 1340 1350 1360 1370 1380
TEELIQNELR ASEILRRGEY FVSNIVDYNV FTERPGERIV MASNSNLEKI LSELFGKENI
1390 1400 1410 1420 1430 1440
PRIGKKRYKF DNTQTYEQLN FDNPLKETSI WYIQNIIDNN NTVFRAFANT YYWLVHPYDE
1450 1460 1470 1480 1490 1500
VSMRNIGYYS PLQTTLSNIY KSQVINWLLQ QENQDMIQKI SSYIRYNKVE DFVTKLSMDV
1510 1520 1530 1540 1550 1560
NTISSGIVEL CILSILYETI IYVNDEYFNV IYVLHPTQGI VYDYKKSKNK FTNEKYQSYK
1570 1580
KVIDIRFRYS SNSNYPDYID ALYPKKNN